CALL FOR DERM2021 E-POSTERS!
DISPLAY AND DISCUSSION OPPORTUNITIES AVAILABLE!
THE SUBMISSION DEADLINE FOR E-POSTERs and DISCUSSION SESSION PRESENTATIONS FOR THE DERM2021 NP/PA CME conference is wednesday, JULY 7, 2021.
POSTER electronic PRESENTATION / DISCUSSION GUIDELINES
If the poster has been previously presented at another conference, it WILL be permitted to be displayed at DERM2021. However, we will NOT allow any duplication of poster data from prior DEF meetings.
Poster abstracts will be published in the DERM2021 Program Syllabus and posters submitted for discussion session may be presented in the general session during the conference. The author(s) will be notified by email if chosen for discussion sessions. The authors do NOT have to participate in DERM2021 or be present. DERM2021 faculty will be presenting posters throughout the live conference.
AVOIDANCE OF COMMERCIALISM
Any poster of which the cost is underwritten to any extent by a pharmaceutical company or other company, must avoid commercialism. Trade names are not to be used for drugs, devices and/or instrumentation, unless absolutely unavoidable. If applicable, posters must include a clear acknowledgment stating the cost was underwritten and identifying the name of the company or companies and their involvement. If the authors did not write the content and a medical education agency or provider was utilized, this should be acknowledged. No advertising matter of any kind may be distributed nor will any material display which, in any way, promotes the commercial interest of any company or the poster authors.
Please read the following poster submission guidelines carefully as the actual e-poster is being submitted along with an accompanying Word document with poster details for consideration by the DEF. Failure to follow these guidelines may result in poster rejection.
PART 1. TO SUBMIT FOR CONSIDERATION FOR E-POSTER DISPLAY ONLY
Submit your e-poster in a .PNG or .JPEG format and your accompanying abstract details in a Microsoft Word document for consideration to the DEF via email to [email protected] Further details for submission are found below.
In a Microsoft Word document, please submit the following for consideration no later than July 7, 2021. E-poster acceptance will be communicated via email no later than 5 business days after submission.
- Poster Title and Author(s)
- Author Affiliation(s)
- Author Financial Disclosures (please limit to relevancy to the poster content)
- Author Contact Information, including email for notification of acceptance status
- Abstract (should not be more than 750 words) to be structured per the following:
- Introduction or Background
- Conclusion or Discussion
- Funding Source, if any, to be stated in the lower right-hand corner
When you submit the Word document for consideration, also submit your e-poster file for consideration in .JPEG or .PNG file no later than July 7, 2021. The file size must be 1080 x 1920 (16:9 portrait), 72 dpi and color profile RGB.
PART 2 – OPTIONAL SUBMISSION FOR CONSIDERATION OF POSTER DISCUSSION PRESENTED BY DERM2021 FACULTY
When you submit PART 1, you may also submit for PART 2. This would include an email submission of not more than five (5) Microsoft® PowerPoint slides to [email protected] by July 7, 2021. These slides should include the poster title, authors, affiliation, and study/abstract results. Relevant graphs and tables must be included. Feel free to include relevant speaker notes to explain in greater detail the visuals provided within the slides. Poster discussion sessions are presented by DERM2021 faculty.
CAUTION: Your poster cannot be selected for PART 2 without meeting the criteria of the submission guidelines for PART 1. They can be separate emails to [email protected]. Poster discussion approvals will be communicated within 5 business days of submission.